AU2666300A - Cdna sequence of an interactor fancip1 of the fanconi anaemia protein of complementation group - Google Patents

Cdna sequence of an interactor fancip1 of the fanconi anaemia protein of complementation group

Info

Publication number
AU2666300A
AU2666300A AU26663/00A AU2666300A AU2666300A AU 2666300 A AU2666300 A AU 2666300A AU 26663/00 A AU26663/00 A AU 26663/00A AU 2666300 A AU2666300 A AU 2666300A AU 2666300 A AU2666300 A AU 2666300A
Authority
AU
Australia
Prior art keywords
fancip1
interactor
protein
cdna sequence
complementation group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26663/00A
Other languages
English (en)
Inventor
Hans Joachim Gross
Sabine Herterich
Holger Hoehn
Tanja Reuter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MultiGene Biotech GmbH
Original Assignee
MultiGene Biotech GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MultiGene Biotech GmbH filed Critical MultiGene Biotech GmbH
Publication of AU2666300A publication Critical patent/AU2666300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
AU26663/00A 1999-02-05 2000-01-24 Cdna sequence of an interactor fancip1 of the fanconi anaemia protein of complementation group Abandoned AU2666300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19904650A DE19904650A1 (de) 1999-02-05 1999-02-05 cDNA-Sequenz eines Interaktors FANCIP1 des Fanconi-Anämie-Proteins der Komplementationsgruppe A
DE19904650 1999-02-05
PCT/EP2000/000506 WO2000046244A1 (de) 1999-02-05 2000-01-24 cDNA-SEQUENZ EINES INTERAKTORS FANCIP1 DES FANCONI-ANÄMIE-PROTEINS DER KOMPLEMENTATIONSGRUPPE A

Publications (1)

Publication Number Publication Date
AU2666300A true AU2666300A (en) 2000-08-25

Family

ID=7896511

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26663/00A Abandoned AU2666300A (en) 1999-02-05 2000-01-24 Cdna sequence of an interactor fancip1 of the fanconi anaemia protein of complementation group

Country Status (3)

Country Link
AU (1) AU2666300A (de)
DE (1) DE19904650A1 (de)
WO (1) WO2000046244A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003088910A2 (en) * 2002-04-15 2003-10-30 Rigel Pharmaceuticals, Inc. Methods of assaying for cell cycle modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1007671B1 (de) * 1997-04-07 2002-02-13 Roche Diagnostics GmbH Fanconi-gen ii

Also Published As

Publication number Publication date
WO2000046244A1 (de) 2000-08-10
DE19904650A1 (de) 2000-08-17

Similar Documents

Publication Publication Date Title
AU3725300A (en) Interleukin 17 receptor-like protein
AU1309599A (en) Signal peptide-containing proteins
AU5885900A (en) Environmental testing chamber
AU6045900A (en) Interaction-activated proteins
AU1608201A (en) Human zven proteins
AU7508100A (en) Human seizure related proteins
AU1574401A (en) Granulocyte peptide homolog zgpa1
AU1881200A (en) Novel proteins
AU2666300A (en) Cdna sequence of an interactor fancip1 of the fanconi anaemia protein of complementation group
AU2691500A (en) Novel polypeptide
AU5911000A (en) Sgip peptides
AU1362101A (en) Novel traf family proteins
AU4778600A (en) Novel polypeptide
AU7353500A (en) Apoptosis proteins
AU2061201A (en) Mammalian dishevelled-associated proteins
AU3506800A (en) Leukocyte- and blood-associated proteins
AU1540701A (en) Novel protein
AU6027500A (en) Proteinaceous coating
AU2574200A (en) Novel tnf receptor-like proteins
AU7487300A (en) Lethal insectidice targets
AU5496500A (en) Retro-inverso peptides derived from interleukin-3
AU7304600A (en) Novel protein
AU2002500A (en) Novel protein
AU3362801A (en) Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and
AU2109200A (en) Polypeptide

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase